AVDAmerican Vanguard Corp.

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Eric G. Wintemute

Location

California, USA

Exchange

NYSE

Website

https://american-vanguard.com

Summary

American Vanguard Corporation develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses.

Company Info

CEO

Eric G. Wintemute

Location

California, USA

Exchange

NYSE

Website

https://american-vanguard.com

Summary

American Vanguard Corporation develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses.

AI Insights for AVD
5 min read

Quick Summary

American Vanguard Corporation is a U.S.-based specialty chemicals company headquartered in Newport Beach, California. The company develops, manufactures, formulates, and markets crop-protection and related chemical products for agricultural, commercial, and consumer uses. Its portfolio includes insecticides, fungicides, herbicides, molluscicides, soil fumigants, plant nutrition products, soil health products, and growth regulators. Its main customers include farmers, crop growers, agricultural distributors, retailers, pest-control channels, and commercial users that need specialty chemical solutions. The business is tied closely to planting activity, crop prices, weather patterns, distributor inventory levels, and global demand for agricultural productivity.

Strengths

•

American Vanguard's main strength is its specialized position in agricultural chemicals rather than a reliance on a single product category.

•

The company has a diversified crop-protection portfolio that includes insecticides, herbicides, fungicides, molluscicides, fumigants, and plant-performance products.

•

It has decades of operating history, having been incorporated in 1969, which gives it experience in regulation, formulation, manufacturing, and agricultural distribution.

•

Recent news suggests that adjusted EBITDA remained relatively stable despite lower sales, indicating some resilience in underlying operations.

•

The low price-to-book valuation may also reflect a potentially attractive asset base if management can restore profitability and generate positive free cash flow.

Key Risks

•

American Vanguard faces significant financial and operating risks because recent results include losses and weak operating income.

•

If the company fails to meet 2026 EBITDA or free cash flow targets, investor confidence could deteriorate further.

•

Agricultural chemical demand is cyclical and can be affected by crop prices, planting decisions, weather, droughts, pest pressure, and distributor inventory corrections.

•

Regulatory restrictions are also a major risk because pesticides, fumigants, and crop-protection chemicals require ongoing approvals and can face environmental or safety scrutiny.

What to Watch

The most recent fundamental data provided shows American Vanguard with quarterly operating revenue of about $116.8 million and total gross profit of about $34.7 million.
The company reported negative net income and negative EPS, indicating that profitability remained under pressure in the reported period.
Operating income was slightly negative, which suggests that gross profit was not yet sufficient to fully absorb operating costs.
Recent company news also points to active restructuring actions, including plans to scale back the Los Angeles facility and relocate headquarters.
No specific partnership or product launch was identified in the provided quarter data, but the company appears focused on refinancing, cost reduction, inventory management, and operational stabilization.

Price Drivers

•

American Vanguard's stock price is being driven heavily by turnaround expectations and the market's confidence in management's 2026 outlook.

•

The provided fundamentals show negative EPS, a net loss, and weak recent operating income, which are clear pressure points for valuation.

•

At the same time, the stock trades at a low price-to-book value, which may attract investors looking for a recovery story if profitability improves.

•

Recent news indicates that full-year 2025 sales declined but adjusted EBITDA remained relatively stable, which gives investors a mixed signal.

•

Additional price drivers include refinancing progress, cost cuts, inventory reductions, free cash flow expectations, crop input demand, weather conditions, and distributor inventory trends.

Recent News

•

Recent reports said American Vanguard's 2025 net sales were about $515 million, down roughly 6% from the prior year.

•

The company reported a GAAP net loss of about $50 million, which was improved from a much larger 2024 loss of about $126 million.

•

Adjusted EBITDA was reported around $39.2 million, roughly stable despite the sales decline.

•

The company secured about $285 million in new term loans, which helped refinance the business without equity dilution.

•

Management also announced cost-cutting and restructuring actions, including scaling back its Los Angeles facility, relocating headquarters, reducing inventory, and targeting 2026 sales of about $530 million to $550 million.

Market Trends

•

American Vanguard operates in the broader agrochemical and crop-input market, which is shaped by global food demand, farm economics, and the need to improve agricultural productivity.

•

Long-term population growth and limited arable land support demand for crop-protection products that help improve yields.

•

At the same time, the industry faces pressure from climate volatility, droughts, changing pest patterns, and regional inventory cycles.

•

Large competitors such as Bayer, BASF, Corteva, FMC, and others are investing in more advanced crop-protection, biological, seed, and precision-agriculture solutions.

•

Regulatory scrutiny and sustainability trends may push the market toward safer chemistries, targeted application, soil health products, and integrated pest-management approaches.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on AVD

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show